- Home
- GILD vs ACN Comparison
GILD vs ACN Comparison
Compare GILD & ACN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- ACN
- Stock Information
- Founded
- GILD 1987
- ACN 1989
- Country
- GILD United States
- ACN Ireland
- Employees
- GILD N/A
- ACN N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- ACN Business Services
- Sector
- GILD Health Care
- ACN Consumer Discretionary
- Exchange
- GILD Nasdaq
- ACN Nasdaq
- Market Cap
- GILD 144.1B
- ACN 161.9B
- IPO Year
- GILD 1992
- ACN N/A
- Fundamental
- Price
- GILD $115.05
- ACN $254.83
- Analyst Decision
- GILD Buy
- ACN Buy
- Analyst Count
- GILD 23
- ACN 21
- Target Price
- GILD $115.68
- ACN $348.90
- AVG Volume (30 Days)
- GILD 5.9M
- ACN 3.9M
- Earning Date
- GILD 11-05-2025
- ACN 09-25-2025
- Dividend Yield
- GILD 2.75%
- ACN 2.32%
- EPS Growth
- GILD 496.80
- ACN 15.02
- EPS
- GILD 5.01
- ACN 12.56
- Revenue
- GILD $28,863,000,000.00
- ACN $68,482,535,999.00
- Revenue This Year
- GILD $2.01
- ACN $8.05
- Revenue Next Year
- GILD $4.03
- ACN $5.41
- P/E Ratio
- GILD $22.96
- ACN $20.29
- Revenue Growth
- GILD 3.81
- ACN 6.21
- 52 Week Low
- GILD $77.74
- ACN $236.67
- 52 Week High
- GILD $121.83
- ACN $398.35
- Technical
- Relative Strength Index (RSI)
- GILD 52.20
- ACN 45.14
- Support Level
- GILD $111.28
- ACN $247.89
- Resistance Level
- GILD $118.13
- ACN $260.40
- Average True Range (ATR)
- GILD 2.06
- ACN 5.51
- MACD
- GILD -0.46
- ACN 1.58
- Stochastic Oscillator
- GILD 39.23
- ACN 57.00
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About ACN Accenture plc (Ireland)
Accenture is a leading IT services firm that provides consulting, system integration, and business process outsourcing to enterprises around the world. Customers of Accenture come from a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture is the world's largest professional services company by headcount with around 800,000 employees in over 120 countries.